Ignite Creation Date:
2024-05-06 @ 3:21 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04609345
Status:
UNKNOWN
Last Update Posted:
2020-10-30
First Post:
2020-10-20
Brief Title:
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Sponsor:
Santen Pharma Malaysia Sdn Bhd
Organization:
Santen Pharma Malaysia Sdn Bhd
Study Overview
Official Title:
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Status:
UNKNOWN
Status Verified Date:
2020-10
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective multi-centre cross sectional observational study to determine the prevalence of ocular surface disease OSD in glaucoma patients nationwide The study also analyses sub group of OSD prevalence stratified according to the treatment types ie preserved preservative-free and combination of preservative-free and preserved eyedrops and illustrates the patient perspective on OSD
Detailed Description:
For this prospective multi-centre cross sectional observational study patients who attend routine eye examination at the medical institutions and who have been diagnosed with primary open-angle glaucoma primary angle-closure glaucoma pseudoexfoliation glaucoma pigment dispersion glaucoma or ocular hypertension will be studied The medical institutions are selected across different regions of Malaysia to assess the nationwide prevalence of OSD in glaucoma patients The routine assessments include Corneal Evaluation Tear Break-Up Time TBUT Hyperemia and Schirmers test whereby the data from these assessments will be collected and analyzed The study will also includes Symptom Evaluation and Questionnaire feedback
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None